3 h. ago Eternal Block Deal: Goldman Sachs Sells Stake Worth Rs 355 Crore In Zomato Parent

Goldman Sachs sold 1.08 crore shares in Zomato to BofA Securities at Rs 329 apiece.

Politics

9 h. ago Defence Stocks Zoom On Bullish GS Note: Azad Engineering, PTC Industries Among Key Gainers

The surge in the defence stock was led by Astra Microwave Ltd., Azad Engineering Ltd. and Data Patterns Ltd. that rose 13.25%, 11.45% and 9.24%, respectively.

Politics

3 d. ago RBI Monetary Policy: Goldman Sachs Chief India Economist Expects Repo Rate Cut Only In December

Santanu Sengupta added that the domestic economy looks resilient despite the external headwinds.

Events

4 d. ago Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure

Goldman Sachs has said the move won't have too much of an impact on Indian pharma companies, as a majority of them rely on generics as the main revenue stream.

Events

5 d. ago US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact

Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US, about 17% of 2024-25 revenue.

Events

7 d. ago Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception

Morgan Stanley believes the impact could be limited, as far as the Indian market is concerned. However, companies like Sun Pharma could be at risk due to their speciality drug presence in the US.

Politics

7 d. ago Trump delivers another bitter tariff pill. Who’s set to bite the dust?

Trump delivers another bitter tariff pill. Who’s set to bite the dust?  The Economic Times

Politics

7 d. ago Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on  Times of India

Politics

7 d. ago Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100%

Other Pharmaceutical stocks seeing decline are Cipla Ltd., Dr Reddys Laboratories Ltd., Lupin Ltd. and Biocon Ltd.

Politics

7 d. ago Sun Pharma Leads Decline As Trump's 100% Tariff Hits Pharma Stocks

Other Pharmaceutical stocks seeing decline are Cipla Ltd., Dr Reddys Laboratories Ltd., Lupin Ltd. and Biocon Ltd.

Politics

9 d. ago Block Deal Today: Goldman Sachs, Morgan Stanley, Others Buy 5% Stake in Akzo Nobel India For Rs 765 Crore

Block Deal Today: Goldman Sachs, Morgan Stanley, others have collectively purchased over 22.77 lakh shares or 5% stake of Akzo Nobel in separate deals.

Economics

9 d. ago Cement Sector To Add Strength? Goldman Sachs Predicts Resilient Q2 Earnings

Cement costs have been generally stable – although pet-coke prices have spiked recently, compounded by the depreciating rupee, Goldman Sachs said.

Politics

9 d. ago Sun Pharma Is Well Poised To Sustain Growth In Focus Segments, Says Motilal Oswal Maintaining 'Buy'

Motilal Oswal expects 14% earnings CAGR over FY25-27E, led by 17% sales CAGR in Sun Pharma's specialty segment and 12% in DF/EM markets, and 160bp margin expansion.

Politics

9 d. ago Stock Picks Today: Infosys, Sun Pharma, Swiggy, Adani Ports, IndusInd Bank On Brokerages' Radar

Infosys Ltd., Sun Pharmaceutical Industries Ltd., Adani Port Ltd., IndusInd Bank Ltd., and Swiggy Ltd., are among the companies garnering brokerage commentary today.

Politics

1 week ago Maruti Suzuki Shares Hit Record High After Goldman Sachs Upgrade

Goldman Sachs has given a target price of Rs 18,900, which is the highest among 48 analysts tracking the company.

Events

1 week ago Goldman Sachs Boosts Hyundai Target Price, Expects Demand Elasticity To Boost Sales

In line with the expected uptick in sales volume, Goldman Sachs has increased its FY27-FY28 earnings per share (EPS) estimates by up to 8%.

Economics

1 week ago JSW Cement Rated 'Neutral' After Goldman Sachs Initiates Coverage

The firm's cautious stance is based on the challenges JSW Cement faces in balancing aggressive growth with profitability and leverage.

Politics

2 w. ago Eternal Share Price Rises For Fourth Day As Goldman Sachs Hikes Target Price

Eternal share price rose 0.99% to Rs 331.5 apiece. The stock has been rising for four sessions.

Events

2 w. ago Stock Picks Today: Sun Pharma, ICICI Bank, Bajaj Finance, Afcons, Yes Bank, Laurus Labs On Brokerages' Radar

Avenue Supermarts Ltd., Shriram Finance Ltd., and Laurus Labs Ltd. are among the companies garnering brokerage commentary today.

Economics

2 w. ago Fears Over India's Fiscal Risk 'Overblown', Says Goldman Sachs

Santanu added that cuts across income tax and GST rates will serve as a boon for the consumption sector.

Events